10-Q: Vireo Growth Inc. Reports Q2 2024 Results, Revenue Up 24% Amidst Strategic Shifts
Quarterly Report
Vireo Growth Inc. saw a 24% increase in revenue in the second quarter of 2024, driven by growth in Maryland, while navigating ongoing legal challenges and strategic asset sales.
Summary
- Vireo Growth Inc. reported a 24% increase in revenue for the three months ended June 30, 2024, reaching $25.1 million, compared to $20.2 million in the same period last year.
- The company's retail revenue increased by 21% to $20.8 million, while wholesale revenue rose by 40% to $4.3 million.
- Maryland operations were a significant driver of growth, contributing 41% of total revenue, while Minnesota contributed 49% and New York 10%.
- Gross profit for the quarter was $13.6 million, with a gross margin of 54%, compared to a 46% gross margin in the same period last year.
- Operating income for the quarter was $5.8 million, a significant improvement from an operating loss of $1.0 million in the prior year.
- The company reported a net loss of $0.7 million for the quarter, compared to a net loss of $7.3 million in the same period last year.
- For the six months ended June 30, 2024, revenue increased by 25% to $49.2 million, compared to $39.3 million in the same period last year.
- The company's net loss for the six months ended June 30, 2024, was $7.4 million, compared to a net loss of $15.7 million in the same period last year.
- The company is actively working on a plan to mitigate going concern issues, including potential asset sales, debt restructuring, and capital raises.
- The company is seeking $860.9 million in damages from Verano due to a breach of contract.
Sentiment
Score: 6
Explanation: The document shows positive revenue growth and improved profitability, but the going concern issues and legal challenges temper the overall sentiment. The company is taking steps to address its financial challenges, but significant risks remain.
Positives
- Revenue increased by 24% in Q2 2024, indicating strong sales growth.
- Gross profit margin improved significantly to 54%, suggesting better cost management and pricing strategies.
- The company achieved operating income of $5.8 million, a substantial improvement from the previous year's loss.
- Net loss decreased significantly, indicating improved financial performance.
- Maryland's adult-use market is driving significant revenue growth.
- The company is actively pursuing legal action against Verano for breach of contract, seeking substantial damages.
- The company is taking steps to address going concern issues through strategic planning.
Negatives
- The company reported a net loss of $0.7 million for the quarter, although it is a significant improvement from the previous year.
- The company is facing substantial doubt about its ability to continue as a going concern.
- The company is involved in ongoing litigation with Verano, which creates uncertainty.
- The company has a significant amount of debt, including long-term debt and convertible notes.
- The company is divesting assets in New York, Nevada, and Massachusetts, which may impact future revenue.
Risks
- The company's ability to continue as a going concern is uncertain due to the termination of the Verano agreement.
- Ongoing litigation with Verano could result in significant costs and uncertainty.
- The company's high debt levels and interest expenses pose a financial risk.
- The company is subject to regulatory risks associated with the cannabis industry.
- The company's divestiture of assets may impact future revenue and profitability.
- The company's access to financing is uncertain.
Future Outlook
The company is focused on becoming more customer-centric and is working to improve its operations. The company is also exploring asset sales, debt restructuring, and capital raises to address its going concern issues. The company expects gradual price compression as markets mature, which could place downward pressure on retail and wholesale gross margins.
Management Comments
- Company management is working with the Company's lenders, counsel, and other applicable parties to implement a plan to effectively mitigate the conditions giving rise to substantial doubt.
- Current management forecasts and related assumptions support the view that we can adequately manage the operational needs of the business.
Industry Context
The cannabis industry is rapidly evolving, with increasing legalization and competition. Vireo Growth is operating in limited-license markets, which provides some protection but also requires navigating complex regulatory environments. The company's focus on customer-centric operations and strategic asset sales reflects broader trends in the industry.
Comparison to Industry Standards
- Compared to other multi-state operators (MSOs) like Curaleaf, Trulieve, and Green Thumb Industries, Vireo Growth's revenue growth of 24% in Q2 2024 is moderate, with some MSOs reporting higher growth rates.
- Vireo's gross margin of 54% is competitive with industry averages, but some MSOs have achieved higher margins through vertical integration and efficient operations.
- The company's operating income of $5.8 million is a positive sign, but many larger MSOs are reporting higher operating profits due to scale and operational efficiencies.
- The company's net loss of $0.7 million is an improvement, but many MSOs are still struggling to achieve consistent profitability.
- The company's legal battle with Verano is a unique challenge, not faced by most other MSOs, and adds significant uncertainty.
- The company's need to explore asset sales, debt restructuring, and capital raises is a sign of financial distress, which is not as common among the larger, more established MSOs.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Joshua Rosen | January 1, 2024 | Joshua Rosen was appointed as CEO |
| Interim Chief Financial Officer | NA | Joshua Rosen | January 1, 2024 | Joshua Rosen was appointed as Interim CFO |
Legal Proceedings
- The company is involved in ongoing litigation with Verano Holdings Corp. regarding the termination of an Arrangement Agreement.
- The company is seeking $860.9 million in damages from Verano for breach of contract.
- The company is involved in a legal proceeding with Dr. Mark Schneyer, which was settled in April 2023.
Related Party Transactions
- As of June 30, 2024, there were $0 due to related parties.
Stakeholder Impact
- Shareholders face uncertainty due to the company's going concern issues and ongoing litigation.
- Employees may be affected by potential asset sales and restructuring.
- Customers may experience changes in product availability and service as the company navigates strategic shifts.
- Creditors face increased risk due to the company's financial challenges.
- Suppliers may be impacted by changes in the company's operations and financial stability.
Next Steps
- The company will continue to work on its plan to mitigate going concern issues, including potential asset sales, debt restructuring, and capital raises.
- The company will continue to pursue legal action against Verano.
- The company will continue to focus on improving its operations and becoming more customer-centric.
- The company will continue to monitor the regulatory environment and adapt its strategies accordingly.
Key Dates
| Date | Description |
|---|---|
| November 23, 2004 | Vireo Growth Inc. was incorporated under the Alberta Business Corporations Act. |
| January 31, 2022 | The company entered into an Arrangement Agreement with Verano Holdings Corp. |
| October 13, 2022 | Vireo Growth received a notice of purported termination of the Arrangement Agreement from Verano. |
| October 21, 2022 | Vireo Growth commenced an action against Verano in the Supreme Court of British Columbia. |
| July 31, 2023 | The company filed a requisition for adjournment of its application to compel Verano's compliance with document production. |
| April 1, 2024 | Binding Letter of Intent for Acquisition of Vireo Health of NY Assets signed with ACE Venture Enterprises, Inc. |
| April 30, 2024 | Short-term extension of the maturity date on the Credit Facility with the Agent. |
| May 2, 2024 | The company filed an application with the Supreme Court of British Columbia for summary determination against Verano. |
| May 21, 2024 | The company executed a $1,200,000 term loan with the Agent. |
| June 14, 2024 | Another short-term extension was executed which extended the maturity date on the Credit Facility to July 31, 2024. |
| June 30, 2024 | End of the reporting period for the quarterly report. |
| July 1, 2024 | The company received $3,600,000 in proceeds related to the repayment of the outstanding current note receivable. |
| July 8, 2024 | The company changed its name to Vireo Growth Inc. |
| July 31, 2024 | The company executed a ninth amendment to the Green Ivy credit agreement with Chicago Atlantic and affiliates. |
| July 31, 2024 | Chicago Atlantic notified the company of its intent to voluntarily convert all outstanding convertible notes. |
Keywords
cannabis, revenue, EBITDA, financial results, legal proceedings, asset sales, debt restructuring, capital raise, Maryland, New York, Minnesota, going concern, adult-use, wholesale, retail
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.